TRAYNOR CAPITAL MANAGEMENT, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
TRAYNOR CAPITAL MANAGEMENT, INC. portfolio value:
$0
portfolio value
TRAYNOR CAPITAL MANAGEMENT, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -17.98K shares | -10.63M | $688.87 | 0 |
| Q2 2022 | share | Increase | +0.24% | 43 shares | -1.9M | $591.13 | 17.98K |
| Q1 2022 | share | Increase | +3.88% | 671 shares | 1.62M | $698.42 | 17.94K |
| Q4 2021 | share | Increase | +15.26% | 2.28K shares | 1.83M | $642.51 | 17.27K |
| Q3 2021 | share | Increase | +10.27% | 1.39K shares | 1.13M | $605.18 | 14.98K |
| Q2 2021 | share | Increase | +7.49% | 947 shares | 1.95M | $558.54 | 13.59K |
| Q1 2021 | share | Increase | +3.96% | 482 shares | 106K | $473.14 | 12.64K |
| Q4 2020 | share | Increase | +19.09% | 1.94K shares | -46K | $483.11 | 12.16K |
| Q3 2020 | share | Increase | +7.19% | 685 shares | -21K | $559.78 | 10.21K |
| Q2 2020 | share | Increase | +53.49% | 3.32K shares | 2.91M | $623.65 | 9.52K |
| Q1 2020 | share | Increase | +111.55% | 3.27K shares | 1.92M | $488.29 | 6.20K |
| Q4 2019 | share | Decrease | -0.47% | -14 shares | 285K | $375.48 | 2.93K |
| Q3 2019 | share | Decrease | -3.38% | -103 shares | -149K | $277.4 | 2.94K |
| Q2 2019 | share | Increase | +2.07% | 62 shares | -261K | $313 | 3.05K |
| Q1 2019 | share | Increase | +85.31% | 1.37K shares | 625K | $410.62 | 2.98K |
| Q4 2018 | share | Increase | +0.56% | 9 shares | -46K | $373.5 | 1.61K |
| Q3 2018 | share | Decrease | -1.66% | -27 shares | 76K | $404.04 | 1.60K |
| Q2 2018 | share | Increase | +9.76% | 145 shares | 61K | $344.99 | 1.63K |
| Q1 2018 | share | Decrease | -3.00% | -46 shares | -64K | $344.36 | 1.48K |
| Q4 2017 | share | Increase | +0.79% | 12 shares | -86K | $375.96 | 1.53K |
| Q3 2017 | share | Decrease | -7.32% | -120 shares | -172K | $447.12 | 1.52K |
| Q2 2017 | share | Decrease | -1.80% | -30 shares | 162K | $491.14 | 1.64K |
| Q1 2017 | share | Decrease | -3.75% | -65 shares | 74K | $387.51 | 1.67K |
| Q4 2016 | share | Decrease | -20.59% | -450 shares | -207K | $367.09 | 1.73K |
| Q3 2016 | share | Decrease | -4.59% | -105 shares | -19K | $402.02 | 2.18K |
| Q2 2016 | share | Decrease | -9.66% | -245 shares | -90K | $349.23 | 2.29K |
| Q1 2016 | share | Decrease | -10.90% | -310 shares | -631K | $360.44 | 2.53K |